ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Consumer Durables

FUJIFILM Holdings Corp.

  • 4,351.00 JPY
  • +66.00
  • +1.54%
  • Japan
    May 22, 2018
  • Ticker
    TKS(4901)
  • Prev. close
    4,285
  • Market cap (JPY)
    2,205.17B
  • Market cap (USD)
    19,827.11M
  • Shares
    514.62M

Business Summary

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Information Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, instant photo systems, etc. The Information Solutions segment deals with the equipment and materials for medical systems, life sciences products, pharmaceuticals, graphic arts, flat panel display materials, recording media and electronic materials, etc. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, paper and consumables, etc. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue2,433.36B21,955.35M
Gross Profit970,011M8,752.05M
Operating income130,679M1,179.06M
Income before tax197,807M1,784.73M
Net income140,694M1,269.43M
EBITDA258,321M2,330.73M
Diluted EPS321.552.90
Dividends Per Share750.67
Total Assets3,492.94B32,843.81M
Total liabilities1,194.23B11,229.27M
Total equity2,079.13B19,549.91M
Operating cash flow261,152M2,356.27M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 2,439.95B 2,492.60B 2,491.62B 2,322.16B 2,433.36B
Gross Profit 921,042M 965,476M 976,632M 930,644M 970,011M
Operating income 144,811M 176,366M 191,179M 172,281M 130,679M
Income before tax 157,154M 197,102M 194,529M 194,775M 197,807M
Net income 80,996M 118,553M 123,313M 131,506M 140,694M
EBITDA 286,251M 299,275M 312,533M 289,916M 258,321M
Diluted EPS 167.63 245.18 264 295.22 321.55
Dividends Per Share 40 60 65 70 75
Total Assets 3,226.96B 3,556.56B 3,363.67B 3,533.18B 3,492.94B
Total liabilities 1,028.74B 1,089.15B 1,079.84B 1,265.13B 1,194.23B
Total equity 2,020.63B 2,232.71B 2,054.45B 2,043.55B 2,079.13B
Operating cash flow 292,532M 263,731M 221,869M 288,619M 261,152M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 24,357.75M 22,689.64M 20,748.95M 21,444.42M 21,955.35M
Gross Profit 9,194.65M 8,788.52M 8,132.88M 8,594.19M 8,752.05M
Operating income 1,445.63M 1,605.42M 1,592.04M 1,590.95M 1,179.06M
Income before tax 1,568.84M 1,794.17M 1,619.93M 1,798.68M 1,784.73M
Net income 808.57M 1,079.16M 1,026.88M 1,214.41M 1,269.43M
EBITDA 2,857.60M 2,724.23M 2,602.61M 2,677.28M 2,330.73M
Diluted EPS 1.67 2.23 2.19 2.72 2.90
Dividends Per Share 0.39 0.54 0.54 0.64 0.67
Total Assets 31,334.35M 29,656.60M 29,927.25M 31,707.69M 32,843.81M
Total liabilities 9,989.27M 9,081.95M 9,607.56M 11,353.59M 11,229.27M
Total equity 19,620.71M 18,617.58M 18,278.86M 18,339.39M 19,549.91M
Operating cash flow 2,920.31M 2,400.68M 1,847.61M 2,665.30M 2,356.27M

Valuation Measures

Mar 2018
PER13.15
ROA4.00%
ROE6.82%
Operating margin5.37%
Profit margin5.78%

Key executives

  • Chairman & Group Chief Executive Officer: Shigetaka Komori
  • President, Group COO & Representative Director: Kenji Sukeno
  • Head-Consolidated Finance & Administration: Shigenobu Inenaga
  • Director & Chief Technology Officer: Yuzo Toda
  • Director & Executive Officer: Norio Shibata

Shareholders

  • FUJIFILM Holdings Corp. (16.3%)
  • Nomura Asset Management Co., Ltd. (3.4%)
  • Nippon Life Insurance Co. (3.4%)
  • Sumitomo Mitsui Financial Group, Inc. (2.0%)
  • The Vanguard Group, Inc. (1.7%)
  • Daiwa Asset Management Co. Ltd. (1.6%)
  • Nikko Asset Management Co., Ltd. (1.5%)
  • BlackRock Fund Advisors (1.4%)
  • MS&AD Insurance Group Holdings, Inc. (1.3%)
  • Daicel Corp. (1.2%)

Contact Details

Related Companies

  • DS Chemport (Australia) Pty Ltd.
  • Fujifilm Co., Ltd.
  • FX Global Supply Solutions, Inc.
  • Fuji Xerox Industry Development (China) Co., Ltd.
  • FUJIFILM Printing Plate (China) Co., Ltd.
  • FUJIFILM Electronic Materials Korea Co., Ltd.
  • FUJIFILM Opt-Electronics (Tianjin) Co., Ltd.
  • Fuji Xerox Eco-Manufacturing (Suzhou) Co., Ltd.
  • FUJIFILM Printing Plate Co., Ltd.
  • FUJIFILM Hungary Ltd.
  • FUJIFILM (Shanghai) Trading Co., Ltd.
  • PT Modern Foto
  • Fujifilm Electronic Materials Taiwan Co., Ltd.
  • Fujitsu General Co, Ltd.
  • FUJIFILM Sericol India Pvt Ltd.
  • FUJIFILM Italia SpA
  • FUJIFILM Hong Kong Ltd.
  • FUJIFILM Holdings France SAS
  • Fuji Xerox of Shenzhen Ltd.
  • Fuji Xerox Industry Development (Shanghai) Co., Ltd.
  • Fuji Xerox Far East Ltd.
  • FX Global, Inc.
  • FUJIFILM (China) Investment Co., Ltd.
  • Salmat Asia Ltd.
  • Fuji Hunt Photographic Chemicals Pte Ltd.
  • Fuji Graphic Systems Canada, Inc.
  • FUJIFILM Corp.
  • Fuji Xerox Eco-Manufacturing Co., Ltd.
  • FUJIFILM Hunt Chemicals Singapore Pte Ltd.
  • Fuji Xerox Taiwan Corp.

Competitors

  • Canon Inc.
  • Eastman Kodak Company
  • Olympus Corp.
  • Sindoh Co., Ltd
  • GoPro, Inc. Class A
  • Vieworks Co., Ltd
  • Hologic, Inc.
  • Glory Science Co., Ltd
  • EOS Imaging SA
  • Infinitt Healthcare Co., Ltd
  • Mauna Kea Technologies SA Class O
  • Uni-Pixel, Inc.
  • Analogic Corporation
  • CEWE Stiftung & Co. KGaA
  • Versum Materials, Inc.
  • Shenzhen Capchem Technology Co., Ltd. Class A
  • Sectra AB Class B
  • IDEXX Laboratories, Inc.
  • Bruker Corporation
  • Biocon Limited
  • BioCryst Pharmaceuticals, Inc.
  • ICB BIOTECHNOLOGY INVESTMENTS LTD
  • Check-Cap Ltd.
  • Coherus BioSciences, Inc.
  • Corium International, Inc.
  • Microbot Medical Inc
  • Momenta Pharmaceuticals, Inc.
  • Motus GI Holdings, Inc.
  • SyntheticMR AB
  • ContraFect Corp.
Last Updated on 22 May, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

3 months for $9

Get unlimited access
NAR site on phone, device, tablet

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media